Intellectual Property Contracts & Agreements in the Life Sciences Tools & Services Industry

162 Contracts & Agreements

Browse by Subcategory

License Agreements (157 contracts from 26 companies)
Trademark Agreements (5 | 4)

Browse by Company

10x Genomics, Inc. (4 contracts)
AbCellera Biologics Inc. (4)
Akoya Biosciences, Inc. (3)
ArcherDX, Inc. (4)
ARQULE INC (6)
Berkeley Lights, Inc. (2)
Bio-Matrix Scientific Group, Inc. (4)
BIOANALYTICAL SYSTEMS INC (1)
BioNano Genomics, Inc (10)
ChromaDex Corp. (23)
CODEXIS INC (22)
Cytek BioSciences, Inc. (1)
ECO SCIENCE SOLUTIONS, INC. (3)
EMMAUS LIFE SCIENCES, INC. (1)
EVIO, INC. (2)
FLUIDIGM CORP (11)
HARVARD BIOSCIENCE INC (2)
IsoPlexis Corp (5)
Miromatrix Medical Inc. (25)
NanoString Technologies Inc (9)
NEOGENOMICS INC (1)
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (8)
Quanterix Corp (5)
RAPID MICRO BIOSYSTEMS, INC. (1)
Repligen Corporation (2)
Seer, Inc. (1)
SeqLL, Inc. (1)
Singular Genomics Systems, Inc. (1)

Recent Contracts

Thirteenth Amendment to the License Agreement, dated July 17, 2023, by and between Miromatrix Medical Inc. and Mayo Foundation for Medical Education and Research (Miromatrix Medical Inc., Filed With SEC on August 14, 2023)
Twelfth Amendment to the License Agreement, dated May 7, 2023, by and between Miromatrix Medical Inc. and Mayo Foundation for Medical Education and Research (Miromatrix Medical Inc., Filed With SEC on August 14, 2023)
Eleventh Amendment to the License Agreement, dated November 1, 2022, by and between Miromatrix Medical Inc. and Mayo Foundation for Medical Education and Research (Miromatrix Medical Inc., Filed With SEC on March 31, 2023)
Amendment No. 1 to the Amended and Restated Exclusive License Agreement Effective the 16th Day of July 2021 Between Stanford University and Purigen Biosystems, Inc., dated... (BioNano Genomics, Inc, Filed With SEC on March 9, 2023)
Amended and Restated Exclusive License Agreement with Equity, dated July 16, 2021, by and between The Board of Trustees of the Leland Stanford Junior University and Purigen... (BioNano Genomics, Inc, Filed With SEC on March 9, 2023)
Trademark License Agreement, dated December 19, 2002, by and between Harvard Bioscience, Inc. and President and Fellows of Harvard College (HARVARD BIOSCIENCE INC, Filed With SEC on March 9, 2023)
Tenth Amendment to the License Agreement, dated March 31, 2022, by and between Miromatrix Medical Inc. and Mayo Foundation for Medical Education and Research (Miromatrix Medical Inc., Filed With SEC on May 16, 2022)
Restated and Amended Exclusive License Agreement, effective as of March 13, 2017, between Dartmouth College and ChromaDex, Inc (ChromaDex Corp., Filed With SEC on May 12, 2022)
Side letter agreement to the Amended and Restated Exclusive License Agreement, effective as of March 13, 2019, between Dartmouth College and ChromaDex, Inc (ChromaDex Corp., Filed With SEC on May 12, 2022)
First Amendment to the Amended and Restated Exclusive License Agreement, effective as of December 29, 2020, between Dartmouth College and ChromaDex, Inc (ChromaDex Corp., Filed With SEC on May 12, 2022)
Second Amendment to the Amended and Restated Exclusive License Agreement, effective as of January 1, 2022, between Dartmouth College and ChromaDex, Inc (ChromaDex Corp., Filed With SEC on May 12, 2022)
Amendment No. 1 to Exclusive License Agreement, dated February 5, 2007, between the Registrant and The Institute for Systems Biology (NanoString Technologies Inc, Filed With SEC on May 10, 2022)
Exclusive License Agreement, dated February 4, 2004, between the Registrant and The Institute for Systems Biology (NanoString Technologies Inc, Filed With SEC on May 10, 2022)
Nineth Amendment to the License Agreement, dated October 21, 2021, by and between Miromatrix Medical Inc. and Mayo Foundation for Medical Education and Research (Miromatrix Medical Inc., Filed With SEC on March 30, 2022)
Eighth amendment to the Mayo License Agreement dated October 21, 2021 between the Company and Mayo Foundation for Medical Education and Research (Miromatrix Medical Inc., Filed With SEC on November 15, 2021)
Exclusive License Agreement, dated September 8, 2011, by and between ChromaDex, Inc. and The Regents of the University of California v (ChromaDex Corp., Filed With SEC on November 3, 2021)
Third Amendment to the License Agreement, executed on July 22, 2021 and effective as of April 10, 2021, by and between IsoPlexis Corporation and Yale University (IsoPlexis Corp, Filed With SEC on August 20, 2021)
License Agreement, dated July 5, 2011 between ChromaDex, Inc. and Cornell University ** v (ChromaDex Corp., Filed With SEC on August 3, 2021)
License Agreement, dated as of March 8, 2017, by and between IsoPlexis Corporation and the California Institute of Technology (IsoPlexis Corp, Filed With SEC on July 20, 2021)
Second Amendment to the License Agreement, dated as of January 8, 2018, by and between IsoPlexis Corporation and Yale University (IsoPlexis Corp, Filed With SEC on July 20, 2021)
Amendment to the License Agreement, dated as of December 19, 2016, by and between IsoPlexis Corporation and Yale University (IsoPlexis Corp, Filed With SEC on July 20, 2021)
Amended and Restated License Agreement, dated as of November 28, 2015, by and between IsoPlexis Corporation and Yale University (IsoPlexis Corp, Filed With SEC on July 20, 2021)
Supply and License Agreement, by and between Biotium, Inc. and Cytek Biosciences, Inc., dated as of September 1, 2020 (Cytek BioSciences, Inc., Filed With SEC on July 2, 2021)
License Agreement, dated May 13, 2013, by and between the Registrant and Thermo CRS, Ltd (RAPID MICRO BIOSYSTEMS, INC., Filed With SEC on June 25, 2021)
Second Amendment to the Patent and Know-How License Agreement, dated February 22, 2021, between the Registrant and Reprise Biomedical, Inc (Miromatrix Medical Inc., Filed With SEC on May 28, 2021)
First Amendment to the Patent and Know-How License Agreement, dated October 3, 2019, between the Registrant and Reprise Biomedical, Inc (Miromatrix Medical Inc., Filed With SEC on May 28, 2021)
Patent and Know-How License Agreement, dated June 30, 2019, between the Registrant and Reprise Biomedical Inc (Miromatrix Medical Inc., Filed With SEC on May 28, 2021)
Seventh Amendment to the Mayo License Agreement, dated February 26, 2021, between the Registrant and Mayo Foundation for Medical Education and Research (Miromatrix Medical Inc., Filed With SEC on May 28, 2021)
Sixth Amendment to the Mayo License Agreement, dated February 28, 2020, between the Registrant and Mayo Foundation for Medical Education and Research (Miromatrix Medical Inc., Filed With SEC on May 28, 2021)
Fifth Amendment to the Mayo License Agreement, dated May 12, 2019, between the Registrant and Mayo Foundation for Medical Education and Research (Miromatrix Medical Inc., Filed With SEC on May 28, 2021)
Fourth Amendment to the Mayo License Agreement, dated January 24, 2018, between the Registrant and Mayo Foundation for Medical Education and Research (Miromatrix Medical Inc., Filed With SEC on May 28, 2021)
Third Amendment to the Mayo License Agreement, dated February 21, 2017, between the Registrant and Mayo Foundation for Medical Education Research (Miromatrix Medical Inc., Filed With SEC on May 28, 2021)
Second Amendment to the Mayo License Agreement, dated September 12, 2017, between the Registrant and Mayo Foundation for Medical Education and Research (Miromatrix Medical Inc., Filed With SEC on May 28, 2021)
First Amendment to the Mayo License Agreement, dated September 20, 2016, between the Registrant and Mayo Foundation for Medical Education and Research (Miromatrix Medical Inc., Filed With SEC on May 28, 2021)
License Agreement, dated December 1, 2014, between the Registrant and Mayo Foundation for Medical Education and Research (the Mayo License Agreement) (Miromatrix Medical Inc., Filed With SEC on May 28, 2021)
License Agreement, dated September 15, 2013, between the Registrant and Mayo Foundation for Medical Education and Research (Miromatrix Medical Inc., Filed With SEC on May 28, 2021)
License Agreement, dated January 1, 2011, between the Registrant and Mayo Foundation for Medical Education and Research (Miromatrix Medical Inc., Filed With SEC on May 28, 2021)
Fifth Amendment to the Minnesota License Agreement, dated February 21, 2021, between the Registrant and the Regents of the University of Minnesota (Miromatrix Medical Inc., Filed With SEC on May 28, 2021)
Fourth Amendment to the Minnesota License Agreement, dated September 15, 2016, between the Registrant and the Regents of the University of Minnesota (Miromatrix Medical Inc., Filed With SEC on May 28, 2021)
Third Amendment to the Minnesota License Agreement, dated December 11, 2014, between the Registrant and the Regents of the University of Minnesota (Miromatrix Medical Inc., Filed With SEC on May 28, 2021)